Neelum Pharmaceutics Ltd
07510787
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
Persons with Significant Control
Ms Azima Neelum Safdar
British · England · Age 47
28a, Queslett Road, Birmingham, B43 6PL
Notified 09/04/2016
Former PSCs
Ms Azima Neelum Safdar
Ceased 01/07/2023
CompanyRankvs 23704+ SIC 86900 peers62
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/01/2026
Net Worth
£499
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£1k
Working capital
Current Assets
£4k
Current Liabilities
£3k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 1.52 | — |
| 2025 | 3.19 | -£6k |
| 2024 | 3.53 | -£7k |
| 2023 | 3.30 | +£9k |
| 2022 | 1.34 | -£1k |
| 2021 | 6.07 | -£4k |
| 2020 | 2.18 | +£35k |
| 2019 | -4.19 | — |
Derived from filed accounts. Not audited figures.